Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs-reducing global inequity

Lancet Glob Health. 2024 Oct;12(10):e1582-e1583. doi: 10.1016/S2214-109X(24)00258-4. Epub 2024 Jul 24.

¹ Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa. Electronic address: [email protected].
² Medicines Patent Pool, Geneva, Switzerland.
³ Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands; ReSViNET Foundation, Zeist, Netherlands.

No abstract available

MeSH terms